Capital Research Global Investors - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 272 filers reported holding BLUEBIRD BIO INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital Research Global Investors ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q4 2020$351,711,000
-19.5%
8,128,284
+0.4%
0.09%
-30.5%
Q3 2020$436,959,000
-11.6%
8,099,325
+0.1%
0.13%
-16.0%
Q2 2020$494,105,000
+57.8%
8,094,771
+18.8%
0.16%
+26.8%
Q1 2020$313,098,000
-47.4%
6,812,412
+0.5%
0.12%
-30.9%
Q4 2019$594,869,000
-4.3%
6,779,133
+0.1%
0.18%
-12.7%
Q3 2019$621,904,000
-26.8%
6,773,083
+1.4%
0.20%
-24.4%
Q2 2019$849,242,000
-19.1%
6,676,427
+0.0%
0.27%
-18.9%
Q1 2019$1,050,089,000
+58.0%
6,674,436
-0.4%
0.33%
+43.5%
Q4 2018$664,584,000
-31.4%
6,699,431
+1.0%
0.23%
-17.7%
Q3 2018$968,610,000
+0.5%
6,634,317
+8.1%
0.28%
+7.2%
Q2 2018$963,599,000
-7.8%
6,139,530
+0.3%
0.26%
-11.4%
Q1 2018$1,045,499,000
-2.3%
6,122,980
+1.9%
0.30%
-5.4%
Q4 2017$1,070,527,000
+39.6%
6,010,817
+7.6%
0.31%
+35.3%
Q3 2017$767,047,000
+33.2%
5,584,617
+1.9%
0.23%
+28.9%
Q2 2017$576,001,000
+27.0%
5,483,117
+9.9%
0.18%
+25.9%
Q1 2017$453,595,000
+56.0%
4,990,045
+5.9%
0.14%
+52.1%
Q4 2016$290,795,000
+7.4%
4,713,042
+18.0%
0.09%
+5.6%
Q3 2016$270,633,000
+38.2%
3,992,809
-11.7%
0.09%
+32.8%
Q2 2016$195,828,000
+1.9%
4,523,635
+0.1%
0.07%
+1.5%
Q1 2016$192,088,000
-32.8%
4,519,722
+1.5%
0.07%
-32.7%
Q4 2015$285,955,000
-24.8%
4,452,741
+0.2%
0.10%
-27.9%
Q3 2015$380,038,000
-48.5%
4,442,293
+1.4%
0.14%
-43.8%
Q2 2015$737,781,000
+53.1%
4,381,900
+9.8%
0.24%
+46.7%
Q1 2015$481,797,000
+35.5%
3,989,375
+2.9%
0.16%
+36.4%
Q4 2014$355,517,000
+182.9%
3,876,111
+10.7%
0.12%
+175.0%
Q3 2014$125,685,000
+8.5%
3,502,915
+16.7%
0.04%
+10.0%
Q2 2014$115,815,000
+72.0%
3,002,715
+1.4%
0.04%
+66.7%
Q1 2014$67,327,000
+22.8%
2,960,748
+13.3%
0.02%
+20.0%
Q4 2013$54,816,000
+97.0%
2,612,792
+153.2%
0.02%
+81.8%
Q3 2013$27,823,0001,032,0000.01%
Other shareholders
BLUEBIRD BIO INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 5,910,687$24,470,0003.71%
Monaco Asset Management SAM 306,142$1,267,0000.55%
Parametrica Management Ltd 90,105$374,0000.41%
Kamunting Street Capital Management, L.P. 55,200$229,0000.31%
Birchview Capital, LP 98,000$406,0000.30%
Kamunting Street Capital Management, L.P. 35,000$145,0000.20%
PDT Partners, LLC 519,477$2,151,0000.19%
Graham Capital Management, L.P. 781,912$3,237,0000.13%
CAXTON ASSOCIATES LP 220,154$911,0000.09%
Baker Brothers Advisors 2,499,715$10,349,0000.06%
View complete list of BLUEBIRD BIO INC shareholders